IASON holds Marketing Authorization for IASOtoc® in 3 countries!
IASON proudly announces that IASOtoc®(Gallium 68Ga edotreotide), a radiopharmaceutical intended for use in positron-emission-tomography, meanwhile is available with Marketing Authorization in France, Germany and Austria. IASOtoc® is mainly used for cancer patients with neuroendocrine tumours (NET).
France: Marketing Authorization number 3400955023692(25) received on 01-07-2016
Austria: Marketing Authorization number 437334(25) received on 07-12-2016
Germany: Marketing Authorization number 983510000 received on 09-12-2016